Takeda Pharmaceutical (TAK) Non-Current Assets: 2018-2025
Historic Non-Current Assets for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $76.9 billion.
- Takeda Pharmaceutical's Non-Current Assets fell 9.23% to $76.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $76.9 billion, marking a year-over-year decrease of 9.23%. This contributed to the annual value of $77.0 billion for FY2025, which is 11.53% down from last year.
- According to the latest figures from Q1 2025, Takeda Pharmaceutical's Non-Current Assets is $76.9 billion, which was down 9.23% from $84.7 billion recorded in Q1 2024.
- Takeda Pharmaceutical's 5-year Non-Current Assets high stood at $96.4 billion for Q1 2021, and its period low was $76.9 billion during Q1 2025.
- Moreover, its 3-year median value for Non-Current Assets was $84.7 billion (2024), whereas its average is $83.0 billion.
- As far as peak fluctuations go, Takeda Pharmaceutical's Non-Current Assets grew by 1.35% in 2021, and later decreased by 9.23% in 2025.
- Over the past 5 years, Takeda Pharmaceutical's Non-Current Assets (MRQ) stood at $96.4 billion in 2021, then fell by 5.48% to $91.1 billion in 2022, then dropped by 4.05% to $87.4 billion in 2023, then fell by 3.10% to $84.7 billion in 2024, then fell by 9.23% to $76.9 billion in 2025.
- Its Non-Current Assets was $76.9 billion in Q1 2025, compared to $84.7 billion in Q1 2024 and $87.4 billion in Q1 2023.